|
Glaxo, Novartis drug combo delays breast cancer
Combining GlaxoSmithKline's Tykerb drug with Novartis's Femara candelay significantly the progression of breast cancer in some women,researchers said on Thursday.
More... |
| All times are GMT -7. The time now is 11:12 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021